{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:04:39Z","timestamp":1792029879536,"version":"4.4.0"},"reference-count":43,"publisher":"BMJ","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40425-019-0527-y","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T11:06:06Z","timestamp":1551265566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":365,"title":["A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1209-5735","authenticated-orcid":false,"given":"Alessio","family":"Cortellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Bersanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Buti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Cannita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Michiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Di Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Tursi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zoratto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Marconcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Malorgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Russano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Anesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Zeppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Filetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Botticelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Carlo","family":"Antonini Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"De Galitiis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppa","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rastelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pergolesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Tudini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Rita","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annagrazia","family":"Pireddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Chiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Ricciuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Iacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gelibter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alberto","family":"Occhipinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Antonio","family":"Ascierto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Ficorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"4","key":"527_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1017\/S0029665115000117","volume":"74","author":"A Laviano","year":"2015","unstructured":"Laviano A, Koverech A, Mari A. Cachexia: clinical features when inflammation drives malnutrition. Proc Nutr Soc. 2015 Nov;74(4):348\u201354.","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"527_CR2","doi-asserted-by":"publisher","first-page":"e0125261","DOI":"10.1371\/journal.pone.0125261","volume":"10","author":"N Taghizadeh","year":"2015","unstructured":"Taghizadeh N, Boezen HM, Schouten, et al. BMI and lifetime changes in BMI and cancer mortality risk. PLoS One. 2015;10(4):e0125261. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0125261\n                    \n                   eCollection 2015.","journal-title":"PLoS One"},{"issue":"9","key":"527_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","volume":"18","author":"H Lennon","year":"2016","unstructured":"Lennon H, Sperrin M, Badrick E, et al. The obesity paradox in Cancer: a review. Curr Oncol Rep. 2016;18(9):56. \n                    https:\/\/doi.org\/10.1007\/s11912-016-0539-4\n                    \n                  .","journal-title":"Curr Oncol Rep"},{"issue":"30","key":"527_CR4","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1200\/JCO.2016.66.7311","volume":"34","author":"L Albiges","year":"2016","unstructured":"Albiges L, Hakimi AA, Xie W, et al. Body mass index and metastatic renal cell carcinoma: clinical and biological correlations. J Clin Oncol. 2016;34(30):3655\u201363. \n                    https:\/\/doi.org\/10.1200\/JCO.2016.66.7311\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"17","key":"527_CR5","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1016\/j.ejca.2015.07.042","volume":"51","author":"S Antoun","year":"2015","unstructured":"Antoun S, Bayar A, Ileana E, et al. High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting. Eur J Cancer. 2015;51(17):2570\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2015.07.042\n                    \n                   Epub 2015 Aug 13.","journal-title":"Eur J Cancer"},{"issue":"3","key":"527_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","volume":"19","author":"JL McQuade","year":"2018","unstructured":"McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol. 2018;19(3):310\u201322 Epub 2018 Feb 12.","journal-title":"Lancet Oncol."},{"issue":"4","key":"527_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s10637-017-0464-x","volume":"35","author":"V Heidelberger","year":"2017","unstructured":"Heidelberger V, Goldwasser F, Kramkimel N, et al. Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients. Investig New Drugs. 2017;35(4):436\u201341. \n                    https:\/\/doi.org\/10.1007\/s10637-017-0464-x\n                    \n                   Epub 2017 Apr 10.","journal-title":"Investig New Drugs"},{"key":"527_CR8","doi-asserted-by":"publisher","unstructured":"Richtig G, Hoeller C, Wolf M, et al. Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study. PLoS One. 2018 ;13(10):e0204729. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0204729\n                    \n                  . eCollection 2018.13.","DOI":"10.1371\/journal.pone.0204729"},{"key":"527_CR9","doi-asserted-by":"publisher","unstructured":"Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2018. \n                    https:\/\/doi.org\/10.1038\/s41591-018-0221-5\n                    \n                   [Epub ahead of print].","DOI":"10.1038\/s41591-018-0221-5"},{"issue":"2","key":"527_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.juro.2013.08.049","volume":"191","author":"B Minana","year":"2014","unstructured":"Minana B, Cozar JM, Palou J, et al. Bladder cancer in Spain 2011: population-based study. J Urol. 2014;191(2):323\u20138.","journal-title":"J Urol"},{"issue":"10","key":"527_CR11","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamadermatol.2013.706","volume":"149","author":"D Ciocan","year":"2013","unstructured":"Ciocan D, Barbe C, Aubin F, et al. Distinctive features of melanoma and its management in elderly patients: a population-based study in France. JAJA Dermatol. 2013;149(10):1150\u20137.","journal-title":"JAJA Dermatol"},{"issue":"5","key":"527_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cllc.2015.02.006","volume":"16","author":"C Gridelli","year":"2015","unstructured":"Gridelli C, Balducci L, Ciardiello F, et al. Treatment of elderly patients with non-small-cell lung Cancer: results of an international expert panel meeting of the Italian Association of Thoracic Oncology. Clin Lung Cancer. 2015;16(5):325\u201333.","journal-title":"Clin Lung Cancer"},{"issue":"Suppl 1","key":"527_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3109\/0284186X.2015.1115121","volume":"55","author":"NH Azawi","year":"2016","unstructured":"Azawi NH, Joergensen SM, Jensen NV, et al. Trends in kidney cancer among the elderly in Denmark, 1980-2012. Acta Oncol. 2016;55(Suppl 1):79\u201384.","journal-title":"Acta Oncol"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228\u201347.","journal-title":"Eur J Cancer"},{"key":"527_CR15","first-page":"690","volume":"58","author":"N Mantel","year":"1963","unstructured":"Mantel N. Chi-square tests with one degree of freedom: extensions of the Mendel-Haenszel procedure. J Am Stat Assoc. 1963;58:690\u2013700.","journal-title":"J Am Stat Assoc"},{"key":"527_CR16","doi-asserted-by":"crossref","unstructured":"Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied logistic regression. Third Edition. New Jersey: John Wiley & Sons (2013).","DOI":"10.1002\/9781118548387"},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation of incomplete observations. J Am Stat Assoc. 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1997","unstructured":"Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1997;17:343\u20136.","journal-title":"Control Clin Trials"},{"key":"527_CR19","doi-asserted-by":"crossref","unstructured":"Cox DR. Regression models and life tables (with discussion). J R Stat Soc Ser B. 1972;74(187\u2013200).","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"527_CR20","doi-asserted-by":"publisher","unstructured":"Goebell PJ, M\u00fcller L, H\u00fcbner A, et al. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry. Urol Oncol. 2018;(10):470.e1\u20139. \n                    https:\/\/doi.org\/10.1016\/j.urolonc.2018.07.007\n                    \n                   Epub 2018 Aug 18.","DOI":"10.1016\/j.urolonc.2018.07.007"},{"issue":"8","key":"527_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.18632\/aging.100482","volume":"4","author":"CT Lutz","year":"2012","unstructured":"Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY). 2012;4(8):535\u201346.","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"527_CR22","doi-asserted-by":"publisher","first-page":"E1076","DOI":"10.1152\/ajpendo.90408.2008","volume":"295","author":"LN Sutherland","year":"2008","unstructured":"Sutherland LN, Capozzi LC, Turchinsky NJ, et al. Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am J Physiol Endocrinol Metab. 2008;295(5):E1076\u201383. \n                    https:\/\/doi.org\/10.1152\/ajpendo.90408.2008\n                    \n                   Epub 2008 Sep 9.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"527_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri2921. Epub 2011 Jan","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85\u201397. \n                    https:\/\/doi.org\/10.1038\/nri2921\n                    \n                  . Epub 2011 Jan.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"527_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40139-017-0154-6","volume":"5","author":"BF Jordan","year":"2017","unstructured":"Jordan BF, Gourgue F, Cani PD. Adipose Tissue metabolism and Cancer progression: novel insights from gut microbiota? Curr Pathobiol Rep. 2017;5(4):315\u201322. \n                    https:\/\/doi.org\/10.1007\/s40139-017-0154-6\n                    \n                   Epub 2017 Oct 24.","journal-title":"Curr Pathobiol Rep"},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2015.00076","volume":"6","author":"T Magrone","year":"2015","unstructured":"Magrone T, Jirillo E. Childhood obesity: immune response and nutritional approaches. Front Immunol. 2015;6:76. \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00076\n                    \n                   eCollection 2015.","journal-title":"Front Immunol"},{"issue":"12","key":"527_CR26","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.2337\/db14-0272","volume":"63","author":"T Seijkens","year":"2014","unstructured":"Seijkens T, Kusters P, Chatzigeorgiou A, Chavakis T, Lutgens E. Immune cell crosstalk in obesity: a key role for costimulation? Diabetes. 2014;63(12):3982\u201391. \n                    https:\/\/doi.org\/10.2337\/db14-0272\n                    \n                  .","journal-title":"Diabetes"},{"issue":"6","key":"527_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2017.11.009","volume":"47","author":"SJ Han","year":"2017","unstructured":"Han SJ, Glatman Zaretsky A, Andrade-Oliveira V, et al. White Adipose Tissue Is a Reservoir for Memory T Cells and Promotes Protective Memory Responses to Infection. Immunity. 2017;47(6):1154\u20131168.e6. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2017.11.009\n                    \n                   Epub 2017 Dec 5.","journal-title":"Immunity"},{"issue":"5","key":"527_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195123","volume":"13","author":"S Singh","year":"2018","unstructured":"Singh S, Facciorusso A, Singh AG, et al. Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis. PLoS One. 2018;13(5):e0195123. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0195123\n                    \n                  .","journal-title":"PLoS One"},{"key":"527_CR29","doi-asserted-by":"publisher","unstructured":"Mullen M, Gonzalez-Perez RR. Leptin-Induced JAK\/STAT Signaling and Cancer Growth. Vaccines (Basel). 2016;4(3). pii: E26. doi: \n                    https:\/\/doi.org\/10.3390\/vaccines4030026\n                    \n                  .","DOI":"10.3390\/vaccines4030026"},{"issue":"11","key":"527_CR30","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamadermatol.2015.1916","volume":"151","author":"M Sanlorenzo","year":"2015","unstructured":"Sanlorenzo M, Vujic I, Daud A, et al. Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression JAMA Dermatol. 2015;151(11):1206\u201312. \n                    https:\/\/doi.org\/10.1001\/jamadermatol.2015.1916\n                    \n                  .","journal-title":"Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression JAMA Dermatol"},{"issue":"4","key":"527_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1158\/1078-0432.CCR-15-1136","volume":"22","author":"M Freeman-Keller","year":"2016","unstructured":"Freeman-Keller M, Kim Y, Cronin H, et al. Nivolumab in resected and Unresectable metastatic melanoma: characteristics of immune-related adverse events and association with outcomes. Clin Cancer Res. 2016;22(4):886\u201394. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1136\n                    \n                  .","journal-title":"Clin Cancer Res"},{"key":"527_CR32","doi-asserted-by":"publisher","unstructured":"Min Lee CK, Li S, Tran DC, et al. Characterization of dermatitis after PD-1\/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study. J Am Acad Dermatol. 2018. pii: S0190\u20139622(18)30831\u20134. doi: \n                    https:\/\/doi.org\/10.1016\/j.jaad.2018.05.035\n                    \n                  . [Epub ahead of print].","DOI":"10.1016\/j.jaad.2018.05.035"},{"issue":"3","key":"527_CR33","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/annonc\/mdw640","volume":"28","author":"JC Osorio","year":"2017","unstructured":"Osorio JC, Ni A, Chaft JE, et al. Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer. Ann Oncol. 2017;28(3):583\u20139. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdw640\n                    \n                  .","journal-title":"Ann Oncol"},{"issue":"3","key":"527_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamaoncol.2017.2925","volume":"4","author":"K Haratani","year":"2018","unstructured":"Haratani K, Hayashi H, Chiba Y, et al. Association of Immune-Related Adverse Events with Nivolumab Efficacy in non-small-cell lung Cancer. JAMA Oncol. 2018;4(3):374\u20138. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2017.2925\n                    \n                  .","journal-title":"JAMA Oncol"},{"issue":"12","key":"527_CR35","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jtho.2017.08.022","volume":"12","author":"S Teraoka","year":"2017","unstructured":"Teraoka S, Fujimoto D, Morimoto T, et al. Early immune-related adverse events and association with outcome in advanced non-small cell lung Cancer patients treated with Nivolumab: a prospective cohort study. J Thorac Oncol. 2017;12(12):1798\u2013805. \n                    https:\/\/doi.org\/10.1016\/j.jtho.2017.08.022\n                    \n                   Epub 2017 Sep 20.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"527_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","volume":"19","author":"F Conforti","year":"2018","unstructured":"Conforti F, Pala L, Bagnardi V, et al. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis. Lancet Oncol. 2018;19(6):737\u201346. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(18)30261-4\n                    \n                   Epub 2018 May 16.","journal-title":"Lancet Oncol"},{"issue":"59","key":"527_CR37","doi-asserted-by":"publisher","first-page":"99336","DOI":"10.18632\/oncotarget.22242","volume":"8","author":"A Botticelli","year":"2017","unstructured":"Botticelli A, Onesti CE, Zizzari I, et al. The sexist behaviour of immune checkpoint inhibitors in cancer therapy? Oncotarget. 2017;8(59):99336\u201346. \n                    https:\/\/doi.org\/10.18632\/oncotarget.22242\n                    \n                  .","journal-title":"Oncotarget"},{"issue":"1","key":"527_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2174\/187152608784139631","volume":"8","author":"V Pallottini","year":"2008","unstructured":"Pallottini V, Bulzomi P, Galluzzo P, et al. Estrogen regulation of adipose tissue functions: involvement of estrogen receptor isoforms. Infect Disord Drug Targets. 2008 Mar;8(1):52\u201360.","journal-title":"Infect Disord Drug Targets"},{"key":"527_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fimmu.2015.00635","volume":"6","author":"D Khan","year":"2015","unstructured":"Khan D, Ahmed SA. The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases. Front Immunol. 2015;6:635. \n                    https:\/\/doi.org\/10.3389\/fimmu.2015.00635\n                    \n                  .","journal-title":"Front Immunol"},{"key":"527_CR40","doi-asserted-by":"publisher","unstructured":"Stocco C. Tissue Physiology and Pathology of Aromatase Steroids. 2012 Jan; 77(1-2): 27\u201335. Published online 2011 Nov 13. doi: \n                    https:\/\/doi.org\/10.1016\/j.steroids.2011.10.013\n                    \n                  .","DOI":"10.1016\/j.steroids.2011.10.013"},{"key":"527_CR41","doi-asserted-by":"publisher","unstructured":"Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science (2013) 339(6123):1084\u20138.\n                    https:\/\/doi.org\/10.1126\/science.1233521\n                    \n                  .","DOI":"10.1126\/science.1233521"},{"issue":"2","key":"527_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","volume":"39","author":"L Yurkovetskiy","year":"2013","unstructured":"Yurkovetskiy L, Burrows M, Khan AA, Graham L, Volchkov P, Becker L, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity. 2013;39(2):400\u201312. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2013.08.013\n                    \n                  .","journal-title":"Immunity"},{"issue":"6371","key":"527_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137. \n                    https:\/\/doi.org\/10.1126\/science.aan3706\n                    \n                  .","journal-title":"Science"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-019-0527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:46:56Z","timestamp":1601056016000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-019-0527-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1186\/s40425-019-0527-y","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients provided written, informed consent to treatment with immunotherapy. All patients alive at the time of data collection provided an informed consent for the present retrospective analysis. The procedures followed were in accordance with the precepts of Good Clinical Practice and the declaration of Helsinki. The study was approved by the respective local ethical committees on human experimentation of each institution, after previous approval by the coordinating center (University of L\u2019Aquila, Internal Review Board protocol number 32865, approved on July 24, 2018).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Alessio Cortellini received grants as speaker by MSD, Astra-Zeneca and Boehringer Ingelheim, gran consultancies by BMS and Ipsen; dr Marcello Tiseo received grant as speaker and advisory role by Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis, Roche, MSD, Boehringer Ingelheim, Otsuka, Pierre Fabre; dr Maria Giuseppa Vitale received travel grants and speaker fees by BMS, Ipsen Astellas, Jansen, Novartis and Pfizer; dr Sebatiano Buti received grants as speaker and advisory role by BMS, Pfizer, MSD, Ipsen, Novartis, Astra-Zeneca; dr. Melissa Bersanelli received honoraria as speaker at scientific events and as consultant for advisory role by BMS and Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"57"}}